Aggressive lymphoma
1 paper studies it4 more mention it
- Humans1
Trial sponsors
Company1 trialPhase 1/260 people
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
1 trialPhase 282 people
Latest
3 papers in 12 monthsJournal of the National Comprehensive Cancer Network
Evaluating Vulnerable Elders Survey-13 and FIL Geriatric Assessment in Older Adults With Aggressive Lymphomas
Cohort study of 105 peopleBiomarkers
Cancer
Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas
Cohort study of 87 peopleBiomarkers
Hematological Oncology
Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First-Line Chemotherapy in Patients With Lymphoma
Cohort study of 58 peopleMuscle
[Rinsho Ketsueki] The Japanese Journal of Clinical Hematology
iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas
ReviewInterventions
Leukemia
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
Non-randomized trial in 77 peoplemTOR inhibitors